importantSYS.SOURCE: TechCrunch• 2026-10-10T03:10:06Z

Elon Musk Accuses Mukesh Ambani of Blocking Starlink India Launch Amid Regulatory Dispute

#policy #india #starlink #regulatory #technology

Elon Musk accuses Mukesh Ambani of obstructing Starlink's India launch to maintain monopolistic control, while the Indian government denies allegations of regulatory bias. The dispute highlights tensions over satellite internet regulations and competition in India's telecom sector.

Elon Musk has accused Indian billionaire Mukesh Ambani of blocking competition.

Read original article

*** END OF TRANSMISSION ***

> WEAK PASSWORD '123456' EXPLOITED IN MAJOR DANISH CPR DATA BREACH > ANTHROPIC SUSPENDS LIVE INTERNET ACCESS FOR INTERNAL AI TESTING AMID CLAUDE EXPLOITATION INCIDENTS > AI SYSTEMS LACK AUTONOMOUS DECISION-MAKING CAPABILITIES > IMPACT OF FOOD PROCESSING ON METABOLIC RESPONSES AND BRAIN REWARD SYSTEMS > ELON MUSK ACCUSES MUKESH AMBANI OF BLOCKING STARLINK INDIA LAUNCH AMID REGULATORY DISPUTE > TELEGRAM DESKTOP IPC INJECTION VULNERABILITY ENABLES ARBITRARY FILE READ AND ACCOUNT TAKEOVER > REVERSE ENGINEERING TOOL FOR CODING AGENTS: REA > ANTHROPIC ADDRESSES AI AGENT CONTROL CHALLENGES BY DISABLING INTERNET ACCESS FOR INTERNAL EVALUATIONS > INITIATION OF CLINICAL TRIAL FOR PRION DISEASE DRUG CANDIDATE > RUST TO C COMPILATION VIA EURYDICE FOR HIGH-ASSURANCE SYSTEMS> WEAK PASSWORD '123456' EXPLOITED IN MAJOR DANISH CPR DATA BREACH > ANTHROPIC SUSPENDS LIVE INTERNET ACCESS FOR INTERNAL AI TESTING AMID CLAUDE EXPLOITATION INCIDENTS > AI SYSTEMS LACK AUTONOMOUS DECISION-MAKING CAPABILITIES > IMPACT OF FOOD PROCESSING ON METABOLIC RESPONSES AND BRAIN REWARD SYSTEMS > ELON MUSK ACCUSES MUKESH AMBANI OF BLOCKING STARLINK INDIA LAUNCH AMID REGULATORY DISPUTE > TELEGRAM DESKTOP IPC INJECTION VULNERABILITY ENABLES ARBITRARY FILE READ AND ACCOUNT TAKEOVER > REVERSE ENGINEERING TOOL FOR CODING AGENTS: REA > ANTHROPIC ADDRESSES AI AGENT CONTROL CHALLENGES BY DISABLING INTERNET ACCESS FOR INTERNAL EVALUATIONS > INITIATION OF CLINICAL TRIAL FOR PRION DISEASE DRUG CANDIDATE > RUST TO C COMPILATION VIA EURYDICE FOR HIGH-ASSURANCE SYSTEMS